Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride may help treat facial hirsutism in women.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Hair disease research is a growing and evolving field in dermatology, with recent significant advances.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

New drugs are improving treatment for hormone-related diseases in small pets.

Hormones control reproduction and are crucial for body balance.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.